Swiss National Bank reduced its position in Boston Scientific Co. (NYSE:BSX – Get Rating) by 6.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,818,400 shares of the medical equipment provider’s stock after selling 376,980 shares during the period. Swiss National Bank […]
Boston Scientific Co. (NYSE:BSX – Get Rating) has been given an average rating of “Buy” by the twenty-one research firms that are presently covering the stock, Marketbeat.com reports. Thirteen research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price objective […]
State Board of Administration of Florida Retirement System decreased its position in Boston Scientific Co. (NYSE:BSX – Get Rating) by 2.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,620,520 shares of the medical equipment provider’s stock after selling 36,320 […]
Boston Scientific (NYSE:BSX – Get Rating) and Titan Medical (NASDAQ:TMDIF – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk. Earnings & Valuation This table compares Boston Scientific and Titan […]
Shell Asset Management Co. cut its position in Boston Scientific Co. (NYSE:BSX – Get Rating) by 18.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 22,226 shares of the medical equipment provider’s stock after selling 5,175 shares during the period. […]